A multicenter, randomized, open label, parallel study to evaluate and compare the efficacy and safety of FK506MR [tacrolimus] vs Prograf [tacrolimus] in combination with MMF [mycophenolate mofetil] and steroids in patients undergoing kidney transplantation and a pharmacokinetics study
Phase of Trial: Phase III
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Methylprednisolone; Mycophenolate mofetil; Prednisolone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 10 Mar 2009 Actual initiation date changed from Apr 2007 to Jul 2007 as reported by ClinicalTrials.gov.
- 10 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 10 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.